10.01.2002
Efficacy and safety of recombinant human activated protein C for severe sepsis
G.R. Bernard, J.-L. Vincent, P.-F. Laterre, S.P. LaRosa, J.-F. Dhainaut, A. Lopez-Rodriguez, J.S. Steingrub, G.E. Garber, J.D. Helterbrand, E.W. Ely, C.J. Fisher Jr, for the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis Study Group
The New England Journal of Medicine, 2001; 344: 699-709